Myriad Genetics Inc (MYGN)

Stockholders Equity

$303.90M

Quarterly · Period ending: · USD

MYGN logo

MYGN Stockholders Equity

Latest reported$303.90M
MYGN Quarterly Shareholders Equity ($73.40M → $303.90M)
High-resolution chart · PNG

MYGN stockholders equity history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Myriad Genetics Inc Stockholders Equity — Quarterly (USD)
Period endingStockholders Equity (USD)
303,900,000
337,400,000
368,000,000
372,800,000
388,100,000
704,900,000
701,100,000
731,700,000
740,500,000
760,000,000
783,200,000
683,400,000
735,200,000
835,200,000
885,800,000
916,600,000
947,400,000
950,100,000
967,800,000
968,600,000
902,500,000
875,200,000
879,900,000
909,300,000
918,200,000
967,200,000
1,077,200,000
1,074,500,000
1,088,900,000
1,081,800,000
1,064,200,000
1,102,200,000
966,100,000
948,300,000
914,200,000
870,900,000
768,400,000
748,200,000
732,900,000
735,500,000
748,100,000
770,200,000
770,800,000
687,100,000
662,100,000
668,898,000
694,241,000
712,150,000
719,000,000
722,242,000
675,971,000
690,272,000
728,594,000
664,929,000
662,120,000
635,567,000
635,660,000
652,193,000
616,764,000
578,994,000
566,792,000
524,460,000
561,101,000
571,111,000
557,581,000
567,346,000
517,326,000
473,136,000
434,219,000
583,927,000
519,746,000
477,044,000
425,655,000
353,296,000
349,468,000
341,748,000
340,363,000
339,189,000
235,850,000
239,869,000
249,781,000
256,700,000
261,646,000
127,688,000
135,673,000
144,041,000
154,003,000
163,617,000
173,276,000
133,489,000
144,105,000
153,766,000
163,486,000
169,998,000
175,441,000
124,017,000
128,869,500
134,738,027
138,567,349
139,272,427
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.